Given the effects of VVΔTKΔN1L on systemic T and NK populations, the VVΔTKΔN1L neoadjuvant therapy regime was repeated in LLC flank tumor-bearing mice in which NK, CD4+ or CD8+ T cells were selectively depleted. Here, CD8A is linked to neoplasm.